Cullen/Frost Bankers, Inc. Teva Pharmaceutical Industries LTD Transaction History

Cullen/Frost Bankers, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$8.36 - $11.37 $2,190 - $2,978	-262 Reduced 56.34%	203 $1,000
Q3 2022 Nov 07, 2022	BUY	$6.86 - $11.95 $1,392 - $2,425	203 Added 77.48%	465 $4,000
Q1 2021 May 05, 2021	SELL	$10.34 - $12.81 $1,127 - $1,396	-109 Reduced 29.38%	262 $3,000
Q2 2020 Aug 05, 2020	SELL	$8.12 - $13.12 $69,978 - $113,068	-8,618 Reduced 95.87%	371 $5,000
Q1 2020 May 01, 2020	BUY	$6.69 - $13.45 $57,654 - $115,912	8,618 Added 2322.91%	8,989 $81,000
Q4 2019 Feb 06, 2020	SELL	$6.53 - $10.72 $5,877 - $9,648	-900 Reduced 70.81%	371 $4,000
Q2 2019 Aug 01, 2019	SELL	$8.12 - $15.72 $10,385 - $20,105	-1,279 Reduced 50.16%	1,271 $12,000
Q1 2019 Apr 30, 2019	BUY	$15.58 - $20.01 $39,729 - $51,025	2,550 New	2,550 $40,000
Q4 2017 Jan 31, 2018	SELL	$11.23 - $19.1 $127,247 - $216,422	-11,331 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$15.41 - $32.17 $174,610 - $364,518	11,331	11,331 $199,000

624

565M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.